对在中国市场上销售的孤儿药物的分析
Wei Zhi1, Meilin Liu1, Dan Yang1
1Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China.
Intractable & rare diseases research
|September 4, 2023
概括
中国中国中国中国.
科学领域:
- 药物经济学 药物经济学
- 公共卫生政策 公共卫生政策
- 罕见疾病研究 罕见疾病研究
背景情况:
- 中国越来越多地关注罕见疾病,导致政策制定.
- 政府的举措旨在改善诊断,治疗,药物获取,并降低患者的成本.
- 孤儿药物已逐步纳入国家医疗保险.
研究的目的:
- 分析目前在中国市场上销售的孤儿药的情况.
- 检查这些药物的制造商,市场状况,适用情况和保险含量.
- 为未来的罕见病政策和药物开发提供见解.
主要方法:
- 在中国市场上销售的106种孤儿药物的数据收集.
- 药物制造商的分析,营销状态和治疗指示.
- 审查将孤儿药物列入国家基本医疗保险目录.
主要成果:
- 有106种孤儿药物可供使用,用于治疗53种罕见疾病.
- 药物来自15个国家,为25种疾病提供多种治疗方法.
- 自2004年以来,七批孤儿药物被添加到医疗保险中.
结论:
- 在中国的孤儿药物供应和保险覆盖方面取得了重大进展.
- 分析为政策改进和战略药物开发提供了一个参考.
- 需要继续努力,以满足罕见疾病患者的需求.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
764
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
764
Analysis of Population Pharmacokinetic Data
293
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
293
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


